Company Filing History:
Years Active: 1999-2025
Title: The Innovative Contributions of Rajiv Lall
Introduction
Rajiv Lall is a notable inventor based in Menomonie, WI (US), recognized for his significant contributions to the field of veterinary medicine. With a total of 13 patents, Lall has developed innovative solutions aimed at improving animal health and welfare.
Latest Patents
Among his latest patents, Lall has created compositions and methods for treating pancreatic enzyme deficiencies in mammals. This composition includes enzymes, L-arginine, and other components designed to address exocrine pancreatic enzyme insufficiencies and gastrointestinal disorders. The innovative formulation not only replaces pancreatic enzymes but also treats the side effects of small intestinal bacterial overgrowth and gastrointestinal mucosal degeneration that can occur with pancreatic enzyme loss. This composition can be conveniently mixed into animal feeds or sprayed onto extruded feeds prior to consumption.
Another significant patent involves ovotransferrin treatment for the reproductive tract. This composition and method focus on maintaining fertility or treating conditions such as retained placenta, reproductive tract infection, or reproductive tract inflammation in animals. By administering ovotransferrin to the reproductive tract, the treatment protects against infections and inflammation, thereby helping to maintain fertility in the animal.
Career Highlights
Rajiv Lall has worked with several companies throughout his career, including Vets Plus, Inc. and R&D Lifesciences. His work in these organizations has allowed him to apply his innovative ideas and contribute to advancements in veterinary health.
Collaborations
Lall has collaborated with notable colleagues such as Daniel J DuBourdieu and Ajay Srivastava, further enhancing his research and development efforts in the field.
Conclusion
Rajiv Lall's innovative patents and contributions to veterinary medicine demonstrate his commitment to improving animal health. His work continues to have a positive impact on the industry, showcasing the importance of innovation in addressing complex health issues in animals.